慢性肺源性心脏病常继发于慢性阻塞性肺病(COPD),患者常存在不同程度的心肺功能不全。同时绝大多数患者血液呈高凝或血栓前状态,可导致肺内广泛微动脉血栓形成,是慢性肺源性心脏病急性发作期病情加重的重要因素[1]。我们采用低分子肝素联合环磷腺苷对慢性肺源性心脏病急性加重期患者进行治疗,并探讨疗效。1资料与方法 Chronic pulmonary heart disease often secondary to chronic obstructive pulmonary disease (COPD), patients often have varying degrees of cardiopulmonary insufficiency. At the same time, the vast majority of patients showed hypercoagulable or prothrombotic blood which could lead to the formation of extensive micro-arterial thrombosis in the lungs, which is an important factor in the exacerbation of chronic cor pulmonale [1]. We use low molecular weight heparin combined with cyclic adenosine monotherapy in patients with acute exacerbation of chronic cor pulmonale, and to explore the efficacy. 1 data and methods